Garcia-Parada Carlos 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Garcia-Parada Carlos
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-04+125,000→ 125,000 totalExercise: $56.49Exp: 2031-01-04→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 125,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on January 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.